Keyword: Thermo Fisher

Markets & Companies

Ramping Up Biomanufacturing Capacity

20.04.2022 -

Biomanufacturing for both traditional biologics and new modalities, such as cell and gene therapies, continues to be an active area of investment for CDMOs/CMOS. Some of...

News

Thermo Fisher Expands US and Swiss Biologics Capacities

04.10.2021 -

US scientific services supplier Thermo Fisher Scientific is investing $82.5 million to expand operations and create 169 jobs at its biologic drug substance manufacturing...

News

Moderna Mobilizes CDMOs for Covid Shot Ramp-up

04.06.2021 -

As it ramps up production on three continents, US Covid-19 vaccine manufacturer Moderna is expanding its collaborations with CDMO suppliers in Europe, the US and Asia. At...

News

Thermo Fisher Acquires PPD for $17.4 Billion

20.04.2021 -

US laboratory equipment maker Thermo Fisher Scientific has agreed to buy compatriot firm PPD, a contract research company for the pharma and biotech industry, for $17.4...

News

Thermo Fisher to Upgrade Bioprocessing Operations

17.03.2021 -

Thermo Fisher Scientific plans to spend more than $600 million to upgrade its bioprocessing operations up to 2022. It aims to more than double current manufacturing...

News

Thermo Fisher Adds Strength in Covid Diagnostics

21.01.2021 -

In another move to boost its position in diagnostics for Covid-19 and other infectious diseases, Thermo Fisher Scientific has signed a definitive agreement to acquire...

News

Thermo Fisher Scientific Invests in Germany and US

22.12.2020 -

To support worldwide development of Covid-19 drugs and vaccines, CDMO Thermo Fisher Scientific is investing in new facilities for its cell and gene therapy portfolio in...

News

Thermo Fisher and Innoforce Plan Chinese JV

12.11.2020 -

US scientific equipment manufacturer Thermo Fisher Scientific and China-based CDMO Innoforce have formed a joint venture to own and operate a new pharma services facility...